Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Retatrutide is currently in Phase 3 clinical trials and is not FDA approved yet
weeks 58 increase to 0.5 mg
The Europe Insulin Drugs And Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Market size is expected to reach USD 10.49 billion in 2026 and grow at a CAGR of 4.27% to reach USD 12.93 billion by 2031
Prior Authorization Support : Since Klinic handles the prior authorization process, you won't have to worry about insurance paperwork
M., et al., for the STEP 1 Study Group
US$ 29.81
US$ 29.23
US$ 25.91
US$ 29.54
US$ 20.37
US$ 22.15
US$ 21.70
US$ 27.78
US$ 20.70
US$ 20.29
US$ 24.88
US$ 21.67
